financetom
Business
financetom
/
Business
/
The Descartes Systems Group Screening Technology Adopted by Givaudan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
The Descartes Systems Group Screening Technology Adopted by Givaudan
Oct 6, 2025 9:58 AM

12:31 PM EDT, 10/06/2025 (MT Newswires) -- Descartes Systems Group ( DSGX ) on Monday said international fragrance and beauty company Givaudan adopted its denied party screening technology to automate compliance checks across its global operations.

The system screens Givaudan's business partners in real time against international denied and sanctioned party lists, replacing manual processes that were slower and more prone to error. Descartes' platform is integrated into Givaudan's internal systems, covering regulatory data from major jurisdictions, including the E.U., North America, and the Asia-Pacific region.

With fragrance and beauty operations in more than 160 locations across 52 countries, Givaudan said the move enhances efficiency and strengthens oversight as trade regulations become increasingly complex. "Our collaboration with Givaudan demonstrates how automated compliance tools can empower global organizations to act with greater supply chain agility, transparency, and integrity," said Shabab Wahdatehagh, VP of Global Trade Intelligence.

Descartes shares were last seen up $0.34 to $131.33 on the Toronto Stock Exchange.

Price: 131.38, Change: +0.39, Percent Change: +0.30

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved